Tevogen Bio Holdings Stock Today
| TVGN Stock | 1.20 0.12 9.09% |
PerformanceVery Weak
| Odds Of DistressLow
|
Tevogen Bio is selling at 1.20 as of the 26th of February 2025; that is 9.09 percent decrease since the beginning of the trading day. The stock's open price was 1.32. Tevogen Bio has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 27th of January 2025 and ending today, the 26th of February 2025. Click here to learn more.
Moving together with Tevogen Stock
Moving against Tevogen Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Tevogen Stock Highlights
| CEO CoFounder | MPH MD |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Tevogen Bio Holdings (TVGN) is traded on NASDAQ Exchange in USA. It is located in 15 Independence Boulevard, Warren, NJ, United States, 07059 and employs 12 people. Tevogen Bio is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 231.07 M. Tevogen Bio Holdings conducts business under Biotechnology sector and is part of Health Care industry. The entity has 175.05 M outstanding shares of which 2.78 M shares are at this time shorted by private and institutional investors with about 0.58 trading days to cover.
Tevogen Bio generates negative cash flow from operations
Check Tevogen Bio Probability Of Bankruptcy
Ownership AllocationTevogen Bio Holdings shows a total of 175.05 Million outstanding shares. Tevogen Bio Holdings has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 91.7 % of Tevogen Bio outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Tevogen Ownership Details
Tevogen Bio Holdings Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Tevogen Bio market risk premium is the additional return an investor will receive from holding Tevogen Bio long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.0135 | |||
| Jensen Alpha | 0.0405 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | 0.0045 |
Tevogen Stock Against Markets
Tevogen Bio Corporate Management
| Susan MBA | Independent Officer | Profile | |
| Mittul Mehta | Chief Tevogenai | Profile | |
| Sadiq Khan | Chief Officer | Profile | |
| Jeffrey MPH | Member Officer | Profile | |
| Tapan Shah | Head Development | Profile | |
| Kirti CPA | Chief Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tevogen Bio. If investors know Tevogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tevogen Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tevogen Bio Holdings is measured differently than its book value, which is the value of Tevogen that is recorded on the company's balance sheet. Investors also form their own opinion of Tevogen Bio's value that differs from its market value or its book value, called intrinsic value, which is Tevogen Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tevogen Bio's market value can be influenced by many factors that don't directly affect Tevogen Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tevogen Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tevogen Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tevogen Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.